Year |
Citation |
Score |
2023 |
Frisch C, Kostes WW, Galyon B, Whitman B, Tekel SJ, Standage-Beier K, Srinivasan G, Wang X, Brafman DA. PINE-TREE enables highly efficient genetic modification of human cell lines. Molecular Therapy. Nucleic Acids. 33: 483-492. PMID 37588683 DOI: 10.1016/j.omtn.2023.07.007 |
0.353 |
|
2022 |
Knittel J, Srinivasan G, Frisch C, Brookhouser N, Raman S, Essuman A, Brafman DA. A microcarrier-based protocol for scalable generation and purification of human induced pluripotent stem cell-derived neurons and astrocytes. Star Protocols. 3: 101632. PMID 36035791 DOI: 10.1016/j.xpro.2022.101632 |
0.42 |
|
2021 |
Cook M, Richey A, Brafman DA, Frow EK. Weighing up the evidence used by direct-to-consumer stem cell businesses. Stem Cell Reports. PMID 34767748 DOI: 10.1016/j.stemcr.2021.10.007 |
0.429 |
|
2021 |
Cutts J, Kostes W, Brafman DA. Generation of 3X FLAG-tagged human embryonic stem cell (hESC) line to study WNT-induced β-catenin DNA interactions (HVRDe009-A-2). Stem Cell Research. 57: 102586. PMID 34736039 DOI: 10.1016/j.scr.2021.102586 |
0.455 |
|
2021 |
Tekel SJ, Brookhouser N, Standage-Beier K, Wang X, Brafman DA. Cytosine and adenosine base editing in human pluripotent stem cells using transient reporters for editing enrichment. Nature Protocols. PMID 34172975 DOI: 10.1038/s41596-021-00552-y |
0.371 |
|
2020 |
Veldhuizen J, Cutts J, Brafman DA, Migrino RQ, Nikkhah M. Engineering anisotropic human stem cell-derived three-dimensional cardiac tissue on-a-chip. Biomaterials. 256: 120195. PMID 32623207 DOI: 10.1016/J.Biomaterials.2020.120195 |
0.421 |
|
2020 |
Raman S, Srinivasan G, Brookhouser N, Nguyen T, Henson T, Morgan D, Cutts J, Brafman DA. A Defined and Scalable Peptide-Based Platform for the Generation of Human Pluripotent Stem Cell-Derived Astrocytes. Acs Biomaterials Science & Engineering. 6: 3477-3490. PMID 32550261 DOI: 10.1021/Acsbiomaterials.0C00067 |
0.49 |
|
2020 |
Raman S, Brookhouser N, Brafman DA. Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer's disease (AD) risk. Neurobiology of Disease. 104788. PMID 32032733 DOI: 10.1016/J.Nbd.2020.104788 |
0.328 |
|
2020 |
Brookhouser N, Tekel SJ, Standage-Beier K, Nguyen T, Schwarz G, Wang X, Brafman DA. BIG-TREE: Base-Edited Isogenic hPSC Line Generation Using a Transient Reporter for Editing Enrichment. Stem Cell Reports. PMID 32004495 DOI: 10.1016/J.Stemcr.2019.12.013 |
0.412 |
|
2020 |
Standage-Beier K, Tekel SJ, Brookhouser N, Schwarz G, Nguyen T, Wang X, Brafman DA. A transient reporter for editing enrichment (TREE) in human cells. Nucleic Acids Research. PMID 31943066 DOI: 10.1093/nar/gkaa027 |
0.323 |
|
2019 |
Standage-Beier K, Tekel SJ, Brookhouser N, Schwarz G, Nguyen T, Wang X, Brafman DA. A transient reporter for editing enrichment (TREE) in human cells. Nucleic Acids Research. PMID 31428784 DOI: 10.1093/Nar/Gkz713 |
0.449 |
|
2019 |
Frow EK, Brafman DA, Muldoon A, Krum L, Williams P, Becker B, Nelson JP, Pritchett A. Characterizing Direct-to-Consumer Stem Cell Businesses in the Southwest United States. Stem Cell Reports. PMID 31378670 DOI: 10.1016/J.Stemcr.2019.07.001 |
0.491 |
|
2018 |
Brookhouser N, Zhang P, Caselli R, Kim JJ, Brafman DA. Generation and characterization of two human induced pluripotent stem cell (hiPSC) lines homozygous for the Apolipoprotein e4 (APOE4) risk variant-Alzheimer's disease (ASUi005-A) and healthy non-demented control (ASUi006-A). Stem Cell Research. 32: 145-149. PMID 30296667 DOI: 10.1016/J.Scr.2018.09.007 |
0.445 |
|
2018 |
Srinivasan G, Morgan D, Varun D, Brookhouser N, Brafman DA. An integrated biomanufacturing platform for the large-scale expansion and neuronal differentiation of human pluripotent stem cell-derived neural progenitor cells. Acta Biomaterialia. PMID 29775730 DOI: 10.1016/J.Actbio.2018.05.008 |
0.506 |
|
2017 |
Brookhouser N, Zhang P, Caselli R, Kim JJ, Brafman DA. Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi003-A) and non-demented control (ASUi004-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant. Stem Cell Research. 25: 266-269. PMID 29246571 DOI: 10.1016/J.Scr.2017.07.003 |
0.441 |
|
2017 |
Huggins IJ, Bos T, Gaylord O, Jessen C, Lonquich B, Puranen A, Richter J, Rossdam C, Brafman D, Gaasterland T, Willert K. The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells. Nature Communications. 8: 1034. PMID 29044119 DOI: 10.1038/S41467-017-01203-1 |
0.714 |
|
2017 |
Brookhouser N, Zhang P, Caselli R, Kim JJ, Brafman DA. Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi001-A) and non-demented control (ASUi002-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant. Stem Cell Research. 24: 160-163. PMID 29034886 DOI: 10.1016/J.Scr.2017.06.003 |
0.441 |
|
2017 |
Brafman D, Willert K. Wnt/β-catenin signaling during early vertebrate neural development. Developmental Neurobiology. PMID 28799266 DOI: 10.1002/Dneu.22517 |
0.712 |
|
2017 |
Brookhouser N, Raman S, Potts C, Brafman DA. May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells. Cells. 6. PMID 28178187 DOI: 10.3390/Cells6010005 |
0.454 |
|
2016 |
Varun D, Rajaram Srinivasan G, Tsai YH, Kim HJ, Cutts J, Petty F, Merkley R, Stephanopoulos N, Dolezalova D, Marsala M, Brafman DA. A robust vitronectin-derived peptide for the scalable long-term expansion and neuronal differentiation of human pluripotent stem cell (hPSC)-derived neural progenitor cells (hNPCs). Acta Biomaterialia. PMID 27989923 DOI: 10.1016/J.Actbio.2016.10.037 |
0.524 |
|
2016 |
Daer R, Cutts JP, Brafman DA, Haynes KA. The impact of chromatin dynamics on Cas9-mediated genome editing in human cells. Acs Synthetic Biology. PMID 27783893 DOI: 10.1021/Acssynbio.5B00299 |
0.316 |
|
2016 |
Huggins IJ, Brafman D, Willert K. Methods to Manipulate and Monitor Wnt Signaling in Human Pluripotent Stem Cells. Methods in Molecular Biology (Clifton, N.J.). 1481: 161-81. PMID 27590161 DOI: 10.1007/978-1-4939-6393-5_16 |
0.76 |
|
2016 |
Kharaziha M, Memic A, Akbari M, Brafman DA, Nikkhah M. Tissue Engineering: Nano-Enabled Approaches for Stem Cell-Based Cardiac Tissue Engineering(Adv. Healthcare Mater. 13/2016). Advanced Healthcare Materials. 5: 1532. PMID 27384932 DOI: 10.1002/Adhm.201670066 |
0.379 |
|
2016 |
Lou CH, Dumdie J, Goetz A, Shum EY, Brafman D, Liao X, Mora-Castilla S, Ramaiah M, Cook-Andersen H, Laurent L, Wilkinson MF. Nonsense-Mediated RNA Decay Influences Human Embryonic Stem Cell Fate. Stem Cell Reports. 6: 844-857. PMID 27304915 DOI: 10.1016/J.Stemcr.2016.05.008 |
0.529 |
|
2016 |
Kharaziha M, Memic A, Akbari M, Brafman DA, Nikkhah M. Nano-Enabled Approaches for Stem Cell-Based Cardiac Tissue Engineering. Advanced Healthcare Materials. PMID 27199266 DOI: 10.1002/Adhm.201600088 |
0.473 |
|
2016 |
Cutts J, Brookhouser N, Brafman DA. Generation of Regionally Specific Neural Progenitor Cells (NPCs) and Neurons from Human Pluripotent Stem Cells (hPSCs). Methods in Molecular Biology (Clifton, N.J.). PMID 27106497 DOI: 10.1007/7651_2016_357 |
0.552 |
|
2015 |
Navaei A, Truong D, Heffernan J, Cutts J, Brafman D, Sirianni RW, Vernon B, Nikkhah M. PNIPAAm-based biohybrid injectable hydrogel for cardiac tissue engineering. Acta Biomaterialia. PMID 26689467 DOI: 10.1016/J.Actbio.2015.12.019 |
0.401 |
|
2015 |
Kumar N, Richter J, Cutts J, Bush KT, Trujillo C, Nigam SK, Gaasterland T, Brafman D, Willert K. Generation of an expandable intermediate mesoderm restricted progenitor cell line from human pluripotent stem cells. Elife. 4. PMID 26554899 DOI: 10.7554/Elife.08413 |
0.746 |
|
2015 |
Brafman D, Campbell S, Lam AQ, Kim JJ, Nikkhah M, Stabenfeldt S. Stem Cell Biology. Biomarker Insights. 10: 133-7. PMID 26339185 DOI: 10.4137/Bmi.S31471 |
0.567 |
|
2015 |
Cutts J, Nikkhah M, Brafman DA. Biomaterial Approaches for Stem Cell-Based Myocardial Tissue Engineering. Biomarker Insights. 10: 77-90. PMID 26052226 DOI: 10.4137/Bmi.S20313 |
0.545 |
|
2015 |
Tsai Y, Cutts J, Kimura A, Varun D, Brafman DA. A chemically defined substrate for the expansion and neuronal differentiation of human pluripotent stem cell-derived neural progenitor cells. Stem Cell Research. 15: 75-87. PMID 26002631 DOI: 10.1016/J.Scr.2015.05.002 |
0.595 |
|
2015 |
Brafman DA. Generation, Expansion, and Differentiation of Human Pluripotent Stem Cell (hPSC) Derived Neural Progenitor Cells (NPCs). Methods in Molecular Biology (Clifton, N.J.). 1212: 87-102. PMID 25063499 DOI: 10.1007/7651_2014_90 |
0.596 |
|
2015 |
Kumar N, Richter J, Cutts J, Bush KT, Trujillo C, Nigam SK, Gaasterland T, Brafman D, Willert K. Author response: Generation of an expandable intermediate mesoderm restricted progenitor cell line from human pluripotent stem cells Elife. DOI: 10.7554/Elife.08413.029 |
0.736 |
|
2015 |
Tsai Y, Cutts J, Kimura A, Varun D, Brafman DA. A chemically defined substrate for the expansion and neuronal differentiation of human pluripotent stem cell-derived neural progenitor cells Stem Cell Research. 15: 75-87. DOI: 10.1016/j.scr.2015.05.002 |
0.489 |
|
2014 |
Ross J, Busch J, Mintz E, Ng D, Stanley A, Brafman D, Sutton VR, Van den Veyver I, Willert K. A rare human syndrome provides genetic evidence that WNT signaling is required for reprogramming of fibroblasts to induced pluripotent stem cells. Cell Reports. 9: 1770-80. PMID 25464842 DOI: 10.1016/J.Celrep.2014.10.049 |
0.698 |
|
2014 |
Moya N, Cutts J, Gaasterland T, Willert K, Brafman DA. Endogenous WNT signaling regulates hPSC-derived neural progenitor cell heterogeneity and specifies their regional identity. Stem Cell Reports. 3: 1015-28. PMID 25458891 DOI: 10.1016/J.Stemcr.2014.10.004 |
0.698 |
|
2014 |
Fernandez A, Huggins IJ, Perna L, Brafman D, Lu D, Yao S, Gaasterland T, Carson DA, Willert K. The WNT receptor FZD7 is required for maintenance of the pluripotent state in human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 111: 1409-14. PMID 24474766 DOI: 10.1073/Pnas.1323697111 |
0.744 |
|
2013 |
Brafman DA, Moya N, Allen-Soltero S, Fellner T, Robinson M, McMillen ZL, Gaasterland T, Willert K. Analysis of SOX2-expressing cell populations derived from human pluripotent stem cells. Stem Cell Reports. 1: 464-78. PMID 24286033 DOI: 10.1016/J.Stemcr.2013.09.005 |
0.745 |
|
2013 |
Brafman DA. Constructing stem cell microenvironments using bioengineering approaches. Physiological Genomics. 45: 1123-35. PMID 24064536 DOI: 10.1152/Physiolgenomics.00099.2013 |
0.587 |
|
2013 |
Brafman DA, Phung C, Kumar N, Willert K. Regulation of endodermal differentiation of human embryonic stem cells through integrin-ECM interactions. Cell Death and Differentiation. 20: 369-81. PMID 23154389 DOI: 10.1038/Cdd.2012.138 |
0.764 |
|
2012 |
Brafman DA, Chien S, Willert K. Arrayed cellular microenvironments for identifying culture and differentiation conditions for stem, primary and rare cell populations. Nature Protocols. 7: 703-17. PMID 22422316 DOI: 10.1038/Nprot.2012.017 |
0.747 |
|
2010 |
Brafman DA, Chang CW, Fernandez A, Willert K, Varghese S, Chien S. Long-term human pluripotent stem cell self-renewal on synthetic polymer surfaces. Biomaterials. 31: 9135-44. PMID 20817292 DOI: 10.1016/J.Biomaterials.2010.08.007 |
0.699 |
|
2009 |
Brafman DA, de Minicis S, Seki E, Shah KD, Teng D, Brenner D, Willert K, Chien S. Investigating the role of the extracellular environment in modulating hepatic stellate cell biology with arrayed combinatorial microenvironments. Integrative Biology : Quantitative Biosciences From Nano to Macro. 1: 513-24. PMID 20023766 DOI: 10.1039/B912926J |
0.68 |
|
2009 |
Brafman DA, Shah KD, Fellner T, Chien S, Willert K. Defining long-term maintenance conditions of human embryonic stem cells with arrayed cellular microenvironment technology. Stem Cells and Development. 18: 1141-54. PMID 19327010 DOI: 10.1089/Scd.2008.0410 |
0.735 |
|
2008 |
De Minicis S, Brafman D, Marzioni M, Seki E, Willert K, Chien S, Benedetti A, Brenner DA. Extracellular matrix combinations differentially modulate hepatic stellate cell biology Digestive and Liver Disease. 40: A132-A133. DOI: 10.1016/J.Dld.2008.07.164 |
0.666 |
|
Show low-probability matches. |